At a glance
ClinicalIndex Comparison RecordN/ACompleted· 897 enrolled
Drug / intervention
Standard of careother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa: a Collaborative Multi-country Prospective Cohort Analysis for International Epidemiologic Databases to Evaluate AIDS- Southern Africa (HIV/HBV-coinfection in IeDEA-SA)
In Brief
An observational study evaluating Standard of care for Hepatitis B Virus and 5 related conditions. Completed, enrolled 897 participants across 1 site.
Detailed Summary
This is a prospective HIV cohort that aims to establish causes of liver disease among HIV-infected individuals in Zambia, including viral hepatitis and alcohol.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHepatitis B Virus, HIV, Antiretroviral Therapy, Africa, Liver Fibrosis, Alcohol Use Disorder
CountriesZambia
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartOct 2013
First PostedFeb 2014
Primary CompletionJan 2021
TodayJul 2026
First PostedFeb 11, 2014
Enrollment StartOct 1, 2013
Primary CompletionJan 1, 2021
TodayJul 2, 2026
Enrollment to primary: 7.3 yearsPosted 12.4 years ago
Interventions
Standard of careother
routine standard of care per Ministry of Health protocol including blood draws and examinations.